Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Immunotherapy × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 210 Carcinoma, Non-Small-Cell Lung 201 Prostatic Neoplasms 160 Multiple Myeloma 105 Colorectal Neoplasms 97 Neoplasms 95 Squamous Cell Carcinoma of Head and Neck 88 Leukemia, Myeloid, Acute 88 Neoplasm Metastasis 80 Lung Neoplasms 80 Melanoma 76 Pancreatic Neoplasms 66 Ovarian Neoplasms 63 Carcinoma, Hepatocellular 63 Triple Negative Breast Neoplasms 62 Recurrence 60 Leukemia, Lymphocytic, Chronic, B-Cell 58 Brain Neoplasms 57 Glioblastoma 53 Lymphoma 52 Carcinoma, Renal Cell 49 Sarcoma 44 Urinary Bladder Neoplasms 43 Lymphoma, Large B-Cell, Diffuse 42 Stomach Neoplasms 41 Endometrial Neoplasms 41 Uterine Cervical Neoplasms 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Head and Neck Neoplasms 40 Rectal Neoplasms 37

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04225390 2026-02-10

PROMIT

University of Erlangen-Nürnberg Medical School

Phase 2 Completed

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡